Morphine Sulfate Injection — FDA Drug Shortage
The FDA lists a drug shortage record for Morphine Sulfate Injection (injection) from Hospira, Inc., A Pfizer Company with status No longer listed by FDA. The shortage was first posted on Jul 8, 2025.
Shortage details
- Status
- No longer listed by FDA
- Company
- Hospira, Inc., A Pfizer Company
- Package NDC
- 0409-1891-23
- Dosage Form
- Injection
- Presentation
- Morphine Sulfate, Injection, 4 mg/1 mL (NDC 0409-1891-23)
- Initial Posting
- Jul 8, 2025